ThomasNet Home   |   Promote Your Business
Home  |   My ThomasNet News®  |   Industry Market Trends  |   Submit Release  |   Advertise  |   About Us Feb 14, 2012  

Detection System uses bionsensors to expand applications.

Print | 
Email |  Comment   Share  
December 20, 2006 - Providing analysis of molecular interactions, label-free Octet System uses biosensors for kinetic analysis and concentration determination for development of antibody and protein therapeutics. Amine Reactive Biosensors can be derivatized individually or in batch mode using standard coupling chemistry, maximizing throughput on Octet System. Suitable for upstream and downstream bioprocessing, Protein A Biosensors require minimal sample preparation and enable 96 determinations in 30 min.

(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
Original Press release

ForteBio, Inc.
1360 Willow Road, Suite 205
Menlo Park, CA, 94025
USA



ForteBio Launches New Biosensors to Increase the Flexibility of the Octet System


MENLO PARK, Calif., Dec. 7 /-- ForteBio, Inc. announced today the launch of the Amine Reactive and Protein A Biosensors for use on ForteBio's Octet System, a label-free, real-time detection system for the analysis of molecular interactions. The new biosensors expand the menu of Octet applications, providing convenient kinetic analysis and concentration determination for the development of antibody and protein therapeutics.

The ForteBio Octet System is currently used by both pharmaceutical and biotechnology companies in applications ranging from target validation to process monitoring. With the new Amine Reactive Biosensors, customers can analyze a wider range of kinetic interactions by directly coupling the target molecule of their choice using familiar techniques.

"The Amine Reactive Biosensors create a more open platform that enables a wider variety of proteins to be directly coupled to the biosensors for the Octet System," said Winnie Wan, CEO of ForteBio, Inc. "This enhancement provides users the flexibility and throughput in kinetic analyses that can support all phases of bioprocessing for selection, screening and validation of therapeutics undergoing development and production."

The Amine Reactive Biosensors can be derivatized individually or in batch mode using a standard coupling chemistry, which maximizes both flexibility and throughput on the Octet System. Customers are already using the Octet System with Amine Reactive Biosensors to accelerate their clonal selection and screening protein affinities. Kinetic analysis on the Octet System is simple, convenient and easily scaled to match workflow.

ForteBio has also further expanded its Octet menu with the launch of the Protein A Biosensors for measuring antibody concentrations in the development and production of therapeutics. By expanding the dynamic range for quantitation, Protein A Biosensors have broad applications for both upstream and downstream bioprocessing. They are easy to use with minimal sample preparation and up to 96 determinations in about 30 minutes. With rapid and accurate turnaround of results, Protein A Biosensors are used in process development laboratories to monitor bioreactor production and to optimize downstream processing such as purification.

A customer presentation and exhibit of ForteBio's Octet System will be at the IBC Antibody Engineering Conference in San Diego, December 10 through 14, Booth 301.

About ForteBio, Inc.
ForteBio is a venture-capital funded life science company providing analytical systems to accelerate the development of therapeutics. These systems enable real-time analysis of biomolecular interactions providing information on affinity, kinetics and concentration. Most importantly, ForteBio's analytical capabilities enable better and faster characterization of drug candidates, thus providing greater value in drug development applications where existing methods have limitations in throughput, performance and cost. The company is headquartered in Menlo Park, California with a wholly owned subsidiary in Shanghai, China. For more information, please visit www.fortebio.com.

CONTACT: Winnie H. Wan, Ph.D., President & Chief Executive Officer of ForteBio, Inc., +1-650-322-1360, ext. 111, or wwan@fortebio.com
Print | 
Email |  Comment   Share  
Contacts: View detailed contact information.


 

Post a comment about this story

Name:
E-mail:
(your e-mail address will not be posted)
Comment title:
Comment:
To submit comment, enter the security code shown below and press 'Post Comment'.
 



 See related product stories
 Newsletters
Industry Market Trends
Has Got It
  • Latest developments
  • Trends
  • Best practices
  • Opinions & Commentary
Get Ahead. Get IMT.
Subscribe Free Today
Subscribe   View Sample

Your Gateway to a Fast Changing World
Product News Alerts
Receive similar stories and other customized news to keep you in the know on the products shaping industry.
Subscribe Free Today
Subscribe   View Sample
 See more product news in:
Sensors, Monitors and Transducers
Test and Measuring Instruments
 More New Product News from this company:
Immunogenicity Assay Kit detects anti-drug antibodies.
Label-Free Instruments are designed for high throughput.
More ....
 Other News from this company:
ForteBio Launches New Octet® RED96 System and Dip and Read(TM) Protein L Biosensor
ForteBio Strengthens Portfolio with New Biosensors for Research and Development
ForteBio Introduces the Octet(TM) System for Antibody and Protein Therapeutics Development
More ....
 Tools for you
Watch Company 
View Company Profile
Company web site
More news from this company
E-Mail Story
Save Story
Search for suppliers of
Biosensors
Join the forum discussion at:
Tools of the Trade


Home  |  My ThomasNet News®  |  Industry Market Trends  |  Submit Release  |  Advertise  |  Contact News  |  About Us
Brought to you by Thomasnet.com        Browse ThomasNet Directory

Copyright © 2012 Thomas Publishing Company
Terms of Use - Privacy Policy